How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.